Skip to content

NewMarket

US · NEU #1616 by market cap Listed 1970
905.83 -20.45 -2.21%
Live - 5344 symbols - heartbeat 300s ago · 2026-10-08 05:23
Pre-market 905.50 -0.04%
After-hours 905.83 0.00%
Market cap
8.33B
P/B
4.53
EPS
44.44
Reader sentiment Are you bullish or bearish on NEU?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Above fair value
548.21 fair value ≈ 649.62 751.04
  • Implied fair-value range of 548.21-751.04, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +39.4% above the average-multiple fair value of 649.62.

Valuation each multiple against its own 5-year range

P/B ratio 4.62 Expensive vs history 71st percentile
5-year average 4.38 · #47 of 56 in Specialty Chemicals
P/E ratio 19.88 Expensive vs history 99th percentile
5-year average 14.62 · #9 of 32 in Specialty Chemicals
P/S ratio 3.10 Expensive vs history 99th percentile
5-year average 1.87 · #48 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
NewMarket (NEU) 8.33B 19.49 4.53 1.30%
Linde (LIN) 223.11B 31.22 5.71 1.28%
Ecolab (ECL) 77.96B 37.33 7.75 1.02%
Sherwin-Williams (SHW) 76.47B 29.06 19.84 1.01%
Air Products & Chemicals (APD) 61.93B -1,324.38 4.46 2.59%
PPG Industries (PPG) 23.36B 15.03 2.77 2.70%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value923.59 Economic moatNarrow UncertaintyHigh

Trading 2.0% below Morningstar's fair value estimate.

Fair value

NewMarket Corp earns a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a high uncertainty rating.

The company's valuation metrics undermine our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 21.6% lies in the bottom 20% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our balanced fair value estimate.

The company's balance sheet is an additional cause for concern. Low leverage can limit a company's ability to invest in growth, potentially reducing shareholder value compared with a balanced use of debt and equity financing. The firm's EBITDA/interest coverage ratio of 20.5, for example, lies in the top 45% compared with peers globally. The company may have too conservative of a balance sheet based on its high EBITDA/interest coverage ratio, potentially underinvesting in growth opportunities and undermining the long-term trajectory of cash flows. This characteristic further promotes our neutral price/fair value ratio.

Economic moat

The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-10-08 05:23:50 · For reference only, not investment advice and not tailored to your situation.